8 November 2019
Industry conferences are an important way of knowledge sharing, staying up to date with regulations and trends and a great way to network and expand your contacts. We attend the most important conferences as well as share our knowledge with the industry.
Next Generation Nicotine Delivery is a conference addressing market trends, product innovation and public health in the nicotine industry.
read more »
21 October 2019
The highest quality of our products and our customers’ SAFETY are Chemnovatic’s priority from the first days of our activity. Due to recent misinformation in the media concerning instances of so called “vaping-related” lung disease in US and vaping industry in general, Chemnovatic would like to express its position on this subject. As a responsible manufacturer, we would like to stress out that all Chemnovatic products are subject to a number of regulations ensuring safe use.
There are few reasons indicating that Chemnovatic is top-quality manufacturer: read more »
16 October 2018
According to the recent study by Public Health England, e-cigarettes are “the most popular stop smoking aid in England”.
Leading UK public health organizations agree, that although not completely risk-free, the e-cigarette is far less harmful than the regular cigarette. They also claim, based on available research, that the risk reduction is estimated to be at least 95%. read more »
11 December 2017
Most vapers are still waiting for a long term study that would support the claims that e-liquids and vaping are much better for people than regular cigarettes. Now there is something we can actually show to the sceptics thanks to Dr. Riccardo Polosa.
Accoriding to a study that was recently presented on the E-Cigarette Summit in London and published in the Nature journal, vapers that have never smoked regular cigarettes experience no apparent long-term negative health effects from vaping.
Research group led by Dr. Riccardo Polosa measured coronary, respiratory and pulmonary vital signs in a group of young vapers with a 3.5 years vaping experience and no prior cigarette smoking history. Similar group of non vapers, no smokers was tested as well as a control group.
Scientists taken into consideration blood pressure, heart rate, exhaled carbon monoxide, high-resolution computed tomography (HRCT) of the lungs and many other aspects and found, that vaping had no negative health effects, it actually shown results to be identical to these of the non smokers, non vapers from the control group.
The results show no significant changes in lung function or structural abnormalities caused by daily exposure to electronic cigarettes. No changes in average heart rate or blood pressure was found even after 3.5 years of vaping – cigarette smokers show signs of lung damage after two years of smoking.
This is the first study showing long-term effects of vaping on people who have never smoked regular cigarettes and is great news for vapers and even better for cigarette smokers who now know that e-cigarettes are less harmful compared to regular cigarettes and a good way of smoking cessation despite the previous biased news stories.
Read full research article here: chemnovatic.com/Files/Health%20impact%20of%20E-cigarettes.pdf
The article was originally published at https://www.nature.com, research conducted by: Riccardo Polosa, Fabio Cibella, Pasquale Caponnetto, Marilena Maglia, Umberto Prosperini, Cristina Russo and Donald Tashkin.
20 October 2017
Welcome again in our series of articles related to REACH and its obligations. Last time we explained what REACH is and today we promised to talk about CLP.
What is CLP then? Does it influence nicotine bases manufacturers?
read more »